Plasma MicroRNA-16 Is a Biomarker for Diagnosis, Stratification, and Prognosis of Hyperacute Cerebral Infarction
Authors:
Open Access
- 15 November 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (11) , e0166688
Abstract
Indices for the diagnosis of hyperacute cerebral infarction (HACI) and the prediction of prognosis are essential for timely and appropriate management. MicroRNAs (miRNAs) that regulate gene expression following stroke have potential use as prognostic markers of HACI. Here, we explored whether concentrations of circulating miRNAs correlate with clinical outcomes and thus form a system of stroke stratification. Plasma samples from patients with HACI (n = 7) and age-matched healthy volunteers (HVT, n = 4) were screened by microarray to find differentially expressed miRNAs, some of which were further verified by quantitative reverse transcription polymerase chain reaction (qRT-PCR) (HACI:HVT = 33:23). The target genes of the miRNAs with verified differential expression were investigated by GO and KEEG analyses. Using the TOAST (OCSP) criteria and the 3-month modified Rankin Score (mRS), relationships among the expression patterns of specific miRNAs, stroke stratification, and clinical prognosis were determined. The microarray analysis revealed 12 differentially expressed miRNAs. Among seven selected miRNAs verified with qRT-PCR, miR-16 expression in the HACI group was the most significantly different from the HVT group (P < 0.01). Bioinformatics analysis showed that the potential target genes of miR-16 were mainly involved in programmed cell death and the p53 signaling pathways. Receiver operating characteristic (ROC) analysis showed that the area under the curve (AUC) of miR-16 was 0.775 (sensitivity 69.7% and specificity 87%) and 0.952 (sensitivity 100% and specificity 91.3%) in overall patients and patients with large artery atherosclerosis (LAAS), respectively. Elevated miR-16 expression was associated with the stroke subtype of LAAS, total anterior circulation infarction, partial anterior circulation infarction, and poor prognosis (P < 0.05). A diagnostic method based on rapid measurement of plasma miR-16 has the potential to identify hyperacute cerebral infarction with LAAS with high sensitivity and specificity, which would inform and improve early treatment decisions and disease management.Keywords
Funding Information
- National Natural Science Foundation of China (31370810)
- Shanghai Municipal Commission of Health and Family Planning (201640094)
This publication has 29 references indexed in Scilit:
- Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in StrokeNew England Journal of Medicine, 2015
- Epigenetic mechanisms of neuroplasticity and the implications for stroke recoveryExperimental Neurology, 2015
- Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2015
- Dynamic metabolites profile of cerebral ischemia/reperfusion revealed by (1)H NMR-based metabolomics contributes to potential biomarkers.2014
- Increase of circulating miR-223 and insulin-like growth factor-1 is associated with the pathogenesis of acute ischemic stroke in patientsBMC Neurology, 2014
- Autophagic effect of programmed cell death 5 (PDCD5) after focal cerebral ischemic reperfusion injury in ratsNeuroscience Letters, 2014
- RETRACTED: Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascadeEuropean Journal of Pharmacology, 2014
- Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humansBMC Neurology, 2013
- MicroRNA-210 as a novel blood biomarker in acute cerebral ischemiaFrontiers in Bioscience-Elite, 2011
- Conservation of miR-15a/16-1 and miR-15b/16-2 clustersMammalian Genome, 2009